Sort   by:  
 Page size 
TranscriptomicsExpression Profiling of a Genetic Animal Model of Depression
Expression Profiling of a Genetic Animal Model of Depression Reveals Novel Molecular Pathways Underlying Depressive-like Behaviours In this study we have used genome-wide microarray expression profiling of the hippocampus and prefrontal/frontal cortex of Flinders Depression Sensitive (FSL) and cont...
ORGANISM(S): Rattus norvegicus 
2010-04-01 | E-GEOD-20388 | biostudies-arrayexpress
UnknownMindfulness-Based Cognitive Therapy for Treatment-Resistant Depression: A protocol for systematic review and meta-analysis.
Not available
S-EPMC11478908 | biostudies-literature
GenomicsBlood transcriptional response to treatment-resistant depression during electroconvulsive therapy
Blood transcriptional response to treatment-resistant depression during electroconvulsive therapy
PRJNA982735 | ENA
GenomicsEpigenetic profiles of response to transcranial magnetic stimulation in treatment resistant depression
Epigenetic profiles of response to transcranial magnetic stimulation in treatment resistant depression
PRJNA1278689 | ENA
TranscriptomicsGene Expression Profiles Predict Postpartum-onset Depression Patients with Treatment-Resistant Depression Patients with Treatment-Resistant Depression
To identify early predictive biomarkers for postpartum depression using peripheral blood gene expression profiles RNA was isolated from peripheral blood collected in Tempus RNA tubes (Applied Biosystems, Darmstadt, Germany) at all three investigated time points for each woman in the discovery sample...
ORGANISM(S): Homo sapiens 
2013-03-29 | E-GEOD-45603 | biostudies-arrayexpress
UnknownPotential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial - CADOT.
Not available
S-EPMC10565009 | biostudies-literature
ProteomicsPeripheral proteomic changes after electroconvulsive seizures (ECS) in a rodent model of non-respons to chronic fluoxetine
Major depressive disorder (MDD) is the psychiatric disorder with the highest prevalence in the world. Pharmacological antidepressant treatment (AD), such as selective serotonin reuptake inhibitors [SSRI, i.e. fluoxetine (Flx)] is the first line of treatment for MDD. Despite its efficacy, lack of AD ...
ORGANISM(S): Mus musculus (Mouse) 
2022-11-01 | PXD037392 | Pride
Pbmc Depression Blood Antidepressant Treatment resistant depression Electrovonvulsive seizure 
UnknownNeurocognitive Predictors of Response in Treatment Resistant Depression to Subcallosal Cingulate Gyrus Deep Brain Stimulation.
Not available
S-EPMC5323405 | biostudies-literature
Methylation profilingEpigenetic profiles of response to transcranial magnetic stimulation in treatment resistant depression
Peripheral blood DNA methylation was profiled in 46 patients with treatment-resistant depression prior to treatment with transcranial magnetic stimulation (TMS). Genome-wide DNA methylation was measured using the Illumina Infinium MethylationEPIC BeadChip (850K array). Following quality control, dat...
ORGANISM(S): Homo sapiens 
2025-06-18 | GSE300009 | GEO
TranscriptomicsBlood transcriptional response to treatment-resistant depression during electroconvulsive therapy
This study aimed to elucidate the transcriptional differences in peripheral blood mononuclear cells (PBMC) between individuals with treatment-resistant depression (TRD) and a control group without a psychiatric illness; and between patients with TRD, treated with either standard antidepressant drugs...
ORGANISM(S): Homo sapiens 
2024-06-30 | GSE234669 | GEO
Sort   by:  
 Page size